| Revenue growth | 15.2% Y-o-Y for FY26. |
|---|---|
| Margins | EBITDA margin 11.9% for FY26; impacted by raw material inflation. |
| Demand visibility | Healthy double-digit growth in HPPC, TSC, and AHN segments. |
| Management confidence | High, citing strong R&D and balanced end-market exposure. |
Growth
FY26 revenue grew 15.2% to ₹2,396.4 cr; PAT grew 9.4% to ₹149.2 cr. Q4 revenue surged 18.2% Y-o-Y.
Outlook
Unitop commissioned 15,000 MTPA ethoxylation capacity. FY27-28 focus on rephased capex, R&D at Koparkhairane, and international expansion.
Risks
Raw material price volatility and lag in passing on cost inflation impacted quarterly margins (11.3% vs 12.0% Y-o-Y).
Earnings Call filed with NSE, NSE: ROSSARI. Summary written with AI assistance from the document.
Rossari Biotech Ltd: key numbers
- Share price
- ₹444.20
- Market cap
- ₹2,461 Cr
- Revenue (annual)
- ₹2,396 Cr
- Net profit (annual)
- ₹149.2 Cr
- P/E (TTM)
- 16.3×Sector 37.5×
- Promoter holding
- 68.14%-0.01% QoQ
- FII holding
- 2.03%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Rossari Biotech Ltd
All →Rossari Biotech Investor Presentation: Key Takeaways
Rossari Biotech achieved its highest-ever quarterly revenue of Rs. 697.2 crore and EBITDA of Rs. 80.6 crore in Q1 FY27, driven by 28% YoY top-line growth and international expansion.
- Call
- Guides 15% growth
Rossari Biotech Earnings Call: Key Takeaways
Rossari Biotech reported record Q1 FY27 revenue of Rs. 697.2 cr (up 28.2% YoY) and EBITDA of Rs. 80.6 cr (up 18.7% YoY), driven by strong demand across core HPPC and TSC segments.
Rossari Biotech Earnings Call: Key Takeaways
Rossari Biotech achieved highest-ever Q4 revenue and EBITDA in FY26, driven by 15% volume-led annual revenue growth. Focus is shifting toward high-margin pharma and oil & gas segments.
Rossari Biotech Q4 FY26 Results: Net Profit ₹46 Cr, Up 33.7% YoY
Rossari Biotech Ltd reported revenue from operations of ₹684.9 Cr (+18.2% YoY) and net profit of ₹46 Cr (+33.7% YoY) for Q4 FY26.
- Key figure
- Net profit ₹46 Cr · +33.7% YoY